- Home
- CVGI vs CNTX Comparison
CVGI vs CNTX Comparison
Compare CVGI & CNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CVGI
- CNTX
- Stock Information
- Founded
- CVGI 2000
- CNTX 2015
- Country
- CVGI United States
- CNTX United States
- Employees
- CVGI N/A
- CNTX N/A
- Industry
- CVGI Auto Parts:O.E.M.
- CNTX Biotechnology: Pharmaceutical Preparations
- Sector
- CVGI Consumer Discretionary
- CNTX Health Care
- Exchange
- CVGI Nasdaq
- CNTX Nasdaq
- Market Cap
- CVGI 76.2M
- CNTX 77.2M
- IPO Year
- CVGI 2004
- CNTX 2021
- Fundamental
- Price
- CVGI $2.19
- CNTX $0.94
- Analyst Decision
- CVGI Buy
- CNTX Strong Buy
- Analyst Count
- CVGI 1
- CNTX 5
- Target Price
- CVGI $10.00
- CNTX $6.70
- AVG Volume (30 Days)
- CVGI 389.2K
- CNTX 1.1M
- Earning Date
- CVGI 03-03-2025
- CNTX 11-06-2024
- Dividend Yield
- CVGI N/A
- CNTX N/A
- EPS Growth
- CVGI N/A
- CNTX N/A
- EPS
- CVGI 1.02
- CNTX N/A
- Revenue
- CVGI $912,995,000.00
- CNTX N/A
- Revenue This Year
- CVGI N/A
- CNTX N/A
- Revenue Next Year
- CVGI N/A
- CNTX N/A
- P/E Ratio
- CVGI $2.21
- CNTX N/A
- Revenue Growth
- CVGI 4.14
- CNTX N/A
- 52 Week Low
- CVGI $2.02
- CNTX $0.89
- 52 Week High
- CVGI $6.97
- CNTX $2.75
- Technical
- Relative Strength Index (RSI)
- CVGI 43.76
- CNTX 38.22
- Support Level
- CVGI $2.15
- CNTX $0.92
- Resistance Level
- CVGI $2.31
- CNTX $1.05
- Average True Range (ATR)
- CVGI 0.13
- CNTX 0.13
- MACD
- CVGI 0.01
- CNTX 0.01
- Stochastic Oscillator
- CVGI 30.19
- CNTX 17.78
About CVGI Commercial Vehicle Group Inc.
Commercial Vehicle Group Inc is a supplier of cab-related products and systems. Its operating segments are Vehicle Solutions, Industrial Automation, Electrical Systems, and Aftermarket and Accessories. Vehicle Solutions segment designs manufacture and sell Commercial vehicle seats and Plastic components. Warehouse Automation segment designs, manufactures, and sells Warehouse automation subsystems including control panels, electro-mechanical assemblies, cable assemblies, and power and communication solutions. Electrical Systems segment designs, manufactures and sells cable and harness assemblies for both high and low voltage applications, control boxes, dashboard assemblies, and design and engineering for these applications. The company makes majority of its revenue from Vehicle Solutions.
About CNTX Context Therapeutics Inc.
Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of innovative therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 ("CLDN6") x anti-CD3 bispecific antibody ("bsAb") that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.